Publication | Open Access
Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy
112
Citations
16
References
2020
Year
These data demonstrate the benefit of idebenone treatment in recovering lost vision and maintaining good residual vision in a real-world setting. Together, these findings indicate that idebenone treatment should be initiated early and be maintained more than 24 months to maximize efficacy. Safety results were consistent with the known safety profile of idebenone.
| Year | Citations | |
|---|---|---|
Page 1
Page 1